1-4 of 4
Julie Wolfson, MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Romidepsin Induces Durable Responses in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Barbara Pro, MD, Steven M. Horwitz, MD, H. Miles Prince, MB BS (Hons) MDFRACP FRCPA AFRACMA MACD, Francine M. Foss, MD, Lubomir Sokol, MD PhD, Matthew Greenwood, MD FRACP, FRCPA, Dolores Caballero, Franck Morschhauser, MD PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, Prof, MD FACP, Swaminathan Padmanabhan Iyer, MD Dir, Hematological Malignancies, Andrei R. Shustov, MD, Julie Wolfson, MPH, Barbara E Balser, VMD, Bertrand Coiffier, MD PhD Prof
Journal: Blood
Blood (2014) 124 (21): 1742.
https://doi.org/10.1182/blood.V124.21.1742.1742
Published: 2014
Journal Articles

Romidepsin Is Effective and Well-Tolerated In Patients ≥ 60 Years Old With Relapsed Or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials

Andrei R. Shustov, MD, Bertrand Coiffier, MD, PhD, Steven M. Horwitz, MD, Lubomir Sokol, MD, Ph.D, Barbara Pro, MD, Tina Nielsen, MD, PhD, Julie Wolfson, MPH, Barbara E Balser, VMD, Robin Eisch, RN, Leslie Popplewell, MD, Miles Prince, MD, FRACP, FRCPA, Steven L. Allen, M.D., Richard Piekarz, MD, PhD, Susan E. Bates, MD
Journal: Blood
Blood (2013) 122 (21): 4385.
https://doi.org/10.1182/blood.V122.21.4385.4385
Published: 2013
Journal Articles

Romidepsin Induces Durable Responses in Patients with Peripheral T-Cell Lymphoma: GPI-06–0002 Study Update

Bertrand Coiffier, MD, PhD, Barbara Pro, MD, Miles Prince, MD, FRACP, FRCPA, Francine M. Foss, MD, Lubomir Sokol, MD, Ph.D, Matthew Greenwood, MD, FRACP, FRCPA, Dolores Caballero, MD, Franck Morschhauser, MD, PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, MD, Swaminathan Padmanabhan, MD, Andrei R. Shustov, MD, Tina Nielsen, MD, PhD, Jean Nichols, PhD, Julie Wolfson, MPH, Barbara E Balser, VMD, Steven M. Horwitz, MD
Journal: Blood
Blood (2012) 120 (21): 3641.
https://doi.org/10.1182/blood.V120.21.3641.3641
Published: 2012
Journal Articles

Exposure-QTc Response Analysis of Class 1 Selective Histone Deacetylase Inhibitor Romidepsin

C.J. Godfrey, PhD, Christopher H. Cabell, MD, MHS, FACC, Barbara Balser, VMD, Julie Wolfson, MPH, Jean Nichols, PhD, Howard A. Burris, III, MD
Journal: Blood
Blood (2011) 118 (21): 2680.
https://doi.org/10.1182/blood.V118.21.2680.2680
Published: 2011